5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The market is segmented by Bionics, Method of Fixation, and Geography
Fastest Growing Market:
The bionics market is expected to register a CAGR of 9.5%, over the forecast period. Factors that are responsible for the growth of the market include increased incidence of disabilities and organ failures, technological advancements, and high incidence of road accidents leading to amputations. Another primary factor is the scarcity of donor organs. The lack of availability of potential organs to transplant has been a major issue. The demand for organ donors is ever increasing, and is very high compared to the actual supply. It has been estimated that of out all the patients who need organ transplantation, only 10% are able to undergo the process. This has been a major boost for the bionics market, as the patients cannot afford to wait in queue since the stakes are very high. Bionics are able to cater to the needs of those in need of organ transplantations and replacements. It can replicate the function of damaged organs. The replication is almost the same. This level of scarcity of organs has turned into a boon for artificial organs and the bionics industry
However, the factors, such as the fear of device malfunction and its consequences, among others, may impact the market growth.
Bionics are man-made devices that can be implanted or integrated into humans, to either replace a natural organ or provide support to restore specific function, or a group of related functions, helping the patient to return to his normal life.
Report scope can be customized per your requirements. Click here.
Implantable bionics held a larger share in the bionics market, in 2018, and it is expected to continue this trend during the forecasted period. This larger market share of implantable bionics is due to the increasing number of organ-failure patient base, as well as the increasing number of patients who are opting for organ transplants across the world. According to the US Government Information on Organ Donation and Transplantation, in 2017, there were 16,473 donors, 34,770 transplants, and 115,759 in the waiting list. Thus, the growing transplant waiting list cases are likely to boost the market growth.
To understand key trends, Download Sample Report
Currently, North America dominates the market for bionics, and is expected to continue its stronghold for a few more years. In the North American region, the United States holds the largest market share. The rising prevalence of chronic diseases and increasing demand for non-invasive surgical procedures are helping in the dominance of the North American region in bionics market. The presence of developed healthcare infrastructure is also expected to propel the market.
To understand geography trends, Download Sample Report.
The bionics market is competitive and consists of numerous major players. In terms of market share, some of the major players currently dominate the bionics market. Owing to the rising adoption of medical bionics and an increasing number of people in need of organs, few other smaller players are expected to enter the market. Some of the major players of the market are Medtronic PLC, BD, Edward Lifesciences Corporation, Baxter AG, and Touch Bionics, among others.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increased Incidence of Disabilities and Organ Failures
4.2.2 Technological Advancements
4.2.3 High Incidence of Road Accidents Leading to Amputations
4.3 Market Restraints
4.3.1 Expensive Procedures
4.3.2 Fear of Device Malfunction and Its Consequences
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1.1 Vision Bionics
5.1.2 Ear Bionics
184.108.40.206 Cochlear Implant
220.127.116.11 Bone-anchored Hearing Aid (BAHA)
5.1.3 Orthopedic Bionic
18.104.22.168 Bionic Hand
22.214.171.124 Bionic Leg
5.1.4 Cardiac Bionics
126.96.36.199 Heart Valves
188.8.131.52 Ventricular-assisted Device
184.108.40.206 Other Cardiac Bionics
5.2 By Fixation
5.2.1 Implantable Bionics
5.2.2 External Bionics
5.3.1 North America
220.127.116.11 United States
18.104.22.168 United Kingdom
22.214.171.124 Rest of Europe
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
5.3.4 Middle East & Africa
184.108.40.206 South Africa
220.127.116.11 Rest of Middle East & Africa
5.3.5 South America
18.104.22.168 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.2 Touch Bionics Inc.
6.1.3 Baxter AG
6.1.4 Cochlear Limited
6.1.5 Cyberonics Inc.
6.1.6 Edward Lifesciences Corporation
6.1.7 Ekso Bionics
6.1.8 Becton, Dickinson and Company
6.1.9 Medtronic PLC
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments